BBLG
$1.23+0.01 (+0.98%)
Market OpenAs of Mar 17, 7:06 PM UTC
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States.
Historical Price
Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$1.23
Potential Upside
5%
Whystock Fair Value$1.29
Price
UndervaluedFair ValueOvervalued
Fundamentals
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.21M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.42
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-70.17%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
12.77
Recent News
BC-Most Active Stocks
td class="col-issue">Next Technology Holding Inc.
Traders Digest Fed's Preferred Inflation Gauge as US Equity Futures Gain Pre-Bell
US equity futures were up ahead of Friday's opening bell as traders digested the Federal Reserve's p